SP1 and neoplasm: A previous study reported that the SUMO E3 ligase protein inhibitor of activated signal transducer and activator of transcription 4 was induced by hypoxia, which prevents Sp1 from binding to the SIRT1 promoter in cancer cells, thereby promoting tumour development [36].